The Netherlands-based KLM Cargo in alliance with European drugs distribution major OPG group has launched their integrated export services solution for Indian pharmaceutical exporters. The new integrated service ranging from managing the entire supply chain, drug registration to initial shipment until products reach end customers, would currently cater to the European markets.

This novel concept in the pharmaceuticals export supply chain management launched by KLM Pharmaceutical Cargo, the KLM-OPG alliance, begins from India to Europe now would expand to Germany, US, Japan and Italy later, said Sanjay Tiwari, director, KLM Pharma Cargo, at the occasion of the service launch on August 23, in Mumbai.

Speaking at the launch, MB (Martijin) Kerstens, managing director, OPG, said that this integrated solution would help Indian pharma exporters to rapidly start up and expand their business in Europe in an effective and law cost way.

In order to familarize this concept to the Indian pharma exporting community, this global cargo company has tied up with the Pharmaceutical Export Promotion Council (Pharmexcil). With the tie-up, KLM Pharma Cargo would offer the members of Pharmexcil cost effective and value added services.

While speaking to Pharmabiz, Sanjay Tiwari, director, KLM Pharmaceutical Cargo, said that with the integrated export solution KLM-OPG alliance lets companies focus on their core business while minimising costs and maximising operational effectiveness.

Similarly, with shipments to and from some 200 destinations in 80 countries, KLM Cargo could provide on-time delivery in perfect condition and in full compliance with the complex transport regulations and increasingly stringent controls imposed by regulatory bodies, he added.

With the strategic alliance between KLM and OPG Group, the venture would utilize services of the key OPG Group players such as Red Swan Pharma Logistics and RegiLabs. Red Swan arranges the receipt, storage and distribution of medicines and other medical supplies to pharmaceutical wholesalers, pharmacists, hospitals, dispensing physicians and chemists while RegiLabs offers extensive tests of raw materials and end products to support batch release and end product registration, ensuring compliance with the European Pharmacopoeia (EP), the British Pharmacopoeia (BP) or the United States Pharmacopoeia (USP).